We are a clinical-stage global biopharmaceutical company developing a pipeline of novel precision therapies for people with cancer.
Recent News
September 28, 2023
AnHeart Therapeutics Appoints Charlotte Arnold as Chief Corporate Affairs Officer
September 7, 2023